A Randomized, Multicenter, Phase III Trial of Tacrolimus/Methotrexate/Ruxolitinib versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Inten
Clinical Trial Grant
Awarded By
National Marrow Donor Program
Start Date
April 21, 2025
End Date
April 27, 2030
Awarded By
National Marrow Donor Program
Start Date
April 21, 2025
End Date
April 27, 2030